Search Results - "MIYAZATO, Paola"

Refine Results
  1. 1
  2. 2

    1mΨ influences the performance of various positive-stranded RNA virus-based replicons by Miyazato, Paola, Noguchi, Takafumi, Ogawa, Fumiyo, Sugimoto, Takeshi, Fauzyah, Yuzy, Sasaki, Ryo, Ebina, Hirotaka

    Published in Scientific reports (31-07-2024)
    “…Self-amplifying RNAs (saRNAs) are versatile vaccine platforms that take advantage of a viral RNA-dependent RNA polymerase (RdRp) to amplify the messenger RNA…”
    Get full text
    Journal Article
  3. 3

    The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome by Satou, Yorifumi, Miyazato, Paola, Ishihara, Ko, Yaguchi, Hiroko, Melamed, Anat, Miura, Michi, Fukuda, Asami, Nosaka, Kisato, Watanabe, Takehisa, Rowan, Aileen G., Nakao, Mitsuyoshi, Bangham, Charles R. M.

    “…Human T-lymphotropic virus type 1 (HTLV-1) is a retrovirus that causes malignant and inflammatory diseases in ∼10% of infected people. A typical host has…”
    Get full text
    Journal Article
  4. 4

    Safety and immunogenicity of parvovirus B19 virus-like particle vaccine lacking phospholipase A2 activity by Suzuki, Hidehiko, Noguchi, Takafumi, Matsugu, Noriko, Suzuki, Akio, Kimura, Sakika, Onishi, Misa, Kosaka, Mitsuyo, Miyazato, Paola, Morita, Eiji, Ebina, Hirotaka

    Published in Vaccine (06-10-2022)
    “…•⊿PLA2 B19 VLPs-immunization did not cause inflammation in mice.•B19 PLA2 domain does not constitute an important human CD4+ T cell epitope.•⊿PLA2 B19 VLPs…”
    Get full text
    Journal Article
  5. 5

    Fusion of parvovirus B19 receptor-binding domain and pneumococcal surface protein A induces protective immunity against parvovirus B19 and Streptococcus pneumoniae by Suzuki, Hidehiko, Noguchi, Takafumi, Ogawa, Keiji, Miyazato, Paola, Hatakeyama, Yu, Morita, Eiji, Ebina, Hirotaka

    Published in Vaccine (23-08-2021)
    “…•B19 RBD alone could not induce neutralizing antibodies due to poor T cell-activation.•RBD-PspA enhanced immunogenicity of RBD, generating parvovirus…”
    Get full text
    Journal Article
  6. 6

    HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo by Satou, Yorifumi, Yasunaga, Jun-Ichirou, Zhao, Tiejun, Yoshida, Mika, Miyazato, Paola, Takai, Ken, Shimizu, Kei, Ohshima, Koichi, Green, Patrick L, Ohkura, Naganari, Yamaguchi, Tomoyuki, Ono, Masahiro, Sakaguchi, Shimon, Matsuoka, Masao

    Published in PLoS pathogens (01-02-2011)
    “…Human T-cell leukemia virus type 1 (HTLV-1) is the causal agent of a neoplastic disease of CD4+ T cells, adult T-cell leukemia (ATL), and inflammatory diseases…”
    Get full text
    Journal Article
  7. 7

    HIV-1 DNA-capture-seq is a useful tool for the comprehensive characterization of HIV-1 provirus by Iwase, Saori C., Miyazato, Paola, Katsuya, Hiroo, Islam, Saiful, Yang, Benjy Tan Jek, Ito, Jumpei, Matsuo, Misaki, Takeuchi, Hiroaki, Ishida, Takaomi, Matsuda, Kouki, Maeda, Kenji, Satou, Yorifumi

    Published in Scientific reports (23-08-2019)
    “…Regardless of recent advances in the development of anti-retroviral drugs, it is still extremely difficult to eradicate HIV-1 from infected individuals. The…”
    Get full text
    Journal Article
  8. 8

    HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors by Kinosada, Haruka, Yasunaga, Jun-Ichirou, Shimura, Kazuya, Miyazato, Paola, Onishi, Chiho, Iyoda, Tomonori, Inaba, Kayo, Matsuoka, Masao

    Published in PLoS pathogens (03-01-2017)
    “…Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia-lymphoma (ATL) and inflammatory diseases. To enhance cell-to-cell transmission of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression by Yamamoto-Taguchi, Nanae, Satou, Yorifumi, Miyazato, Paola, Ohshima, Koichi, Nakagawa, Masanori, Katagiri, Koko, Kinashi, Tatsuo, Matsuoka, Masao

    Published in PLoS pathogens (01-09-2013)
    “…Human T-cell leukemia virus type 1 (HTLV-1) causes both a neoplastic disease and inflammatory diseases, including HTLV-1-associated myelopathy/tropical spastic…”
    Get full text
    Journal Article
  11. 11

    HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP by Miyazato, Paola, Matsuo, Misaki, Tan, Benjy J Y, Tokunaga, Michiyo, Katsuya, Hiroo, Islam, Saiful, Ito, Jumpei, Murakawa, Yasuhiro, Satou, Yorifumi

    Published in Retrovirology (16-12-2019)
    “…Human T cell leukaemia virus type 1 (HTLV-1) is a retrovirus associated with human diseases such as adult T-cell leukaemia/lymphoma and HTLV-1 associated…”
    Get full text
    Journal Article
  12. 12

    Protocol to isolate temperature-sensitive SARS-CoV-2 mutants and identify associated mutations by Okamura, Shinya, Yoshida, Akiho, Miyazato, Paola, Matsumoto, Mai, Ebina, Hirotaka

    Published in STAR protocols (16-06-2023)
    “…An inability to proliferate at high temperatures typically gives viruses an attenuated phenotype. Here, we present a protocol to obtain and isolate…”
    Get full text
    Journal Article
  13. 13

    Human T-cell leukemia virus type 1 and Foxp3 expression: viral strategy in vivo by Miyazato, Paola, Matsuoka, Masao

    Published in International immunology (01-08-2014)
    “…Human T-cell leukemia virus type 1 (HTLV-1) is the causal agent of adult T-cell leukemia (ATL) and inflammatory diseases, including HTLV-1-associated…”
    Get full text
    Journal Article
  14. 14

    Transcriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 Provirus by Miyazato, Paola, Matsuo, Misaki, Katsuya, Hiroo, Satou, Yorifumi

    Published in Viruses (16-06-2016)
    “…Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus associated with human diseases, such as adult T-cell leukemia (ATL) and HTLV-1-associated…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Impact of HIV-1 infection pathways on susceptibility to antiviral drugs and on virus spread by Shimura, Kazuya, Miyazato, Paola, Oishi, Shinya, Fujii, Nobutaka, Matsuoka, Masao

    Published in Virology (New York, N.Y.) (01-10-2015)
    “…Abstract The infection routes of HIV-1 can affect several viral properties, including dissemination, pathogenesis, and immune evasion. In this study, we…”
    Get full text
    Journal Article
  17. 17

    IL-2/IL-2 Receptor Pathway Plays a Crucial Role in the Growth and Malignant Transformation of HTLV-1-Infected T Cells to Develop Adult T-Cell Leukemia by Maeda, Michiyuki, Tanabe-Shibuya, Junko, Miyazato, Paola, Masutani, Hiroshi, Yasunaga, Jun-Ichirou, Usami, Kazumasa, Shimizu, Akira, Matsuoka, Masao

    Published in Frontiers in microbiology (06-03-2020)
    “…T cells infected with human T-cell leukemia virus type 1 (HTLV-1) transform into malignant/leukemic cells and develop adult T-cell leukemia (ATL) after a long…”
    Get full text
    Journal Article
  18. 18

    Dynamics and mechanisms of clonal expansion of HIV-1-infected cells in a humanized mouse model by Satou, Yorifumi, Katsuya, Hiroo, Fukuda, Asami, Misawa, Naoko, Ito, Jumpei, Uchiyama, Yoshikazu, Miyazato, Paola, Islam, Saiful, Fassati, Ariberto, Melamed, Anat, Bangham, Charles R. M., Koyanagi, Yoshio, Sato, Kei

    Published in Scientific reports (31-07-2017)
    “…Combination anti-retroviral therapy (cART) has drastically improved the clinical outcome of HIV-1 infection. Nonetheless, despite effective cART, HIV-1…”
    Get full text
    Journal Article
  19. 19

    Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity by Yoshida, Akiho, Okamura, Shinya, Torii, Shiho, Komatsu, Sayuri, Miyazato, Paola, Sasaki, Hitomi, Ueno, Shiori, Suzuki, Hidehiko, Kamitani, Wataru, Ono, Chikako, Matsuura, Yoshiharu, Takekawa, Shiro, Yamanishi, Koichi, Ebina, Hirotaka

    Published in iScience (18-11-2022)
    “…Live-attenuated vaccines are generally highly effective. Here, we aimed to develop one against SARS-CoV-2, based on the identification of three types of…”
    Get full text
    Journal Article
  20. 20